Workshop Name：1st Large Language Models for Spatial-rich Data Management (LLM+Spatial)

The Hebrew University of Jerusalem is proud to announce that Dr. Chaim Garfinkel, Professor in the Institute of Earth Sciences, has been named a 2025 Laureate of the Blavatnik Awards for Young Scientists in Israel, one of the country’s most prestigious honors for early-career researchers.

The Blavatnik Family Foundation, the Israel Academy of Sciences and Humanities, and The New York Academy of Sciences announced today the Laureates of the prestigious 2025 Blavatnik Awards for Young Scientists in Israel.  This year’s Laureates, who will each receive US$100,000, are:

Yonatan Stelzer, PhD (Life Sciences) – Weizmann Institute of Science – Recognized for breakthroughs in modeling the intricate process of mammalian embryonic development and for advancing our understanding of epigenetics, holding significant promise for regenerative and therapeutic medicine.

Benjamin Palmer, PhD (Chemical Sciences) – Ben-Gurion University of the Negev – Recognized for pioneering research on how organisms create crystals, revealing the biological processes underlying their formation and the unique ways they interact with light, leading to the emerging field of organic biomineralization and inspiring sustainable optical materials.

Chaim Garfinkel, PhD (Physical Sciences & Engineering) – The Hebrew University of Jerusalem – Recognized for advancing our ability to predict climate change on timescales from months to decades, improving weather forecast systems and providing critical insights for climate policy and adaptation strategies.

Depression imposes a staggering global socioeconomic burden. Current pharmacotherapies face major limitations, including slow efficacy, adverse effects, and non-response rates of up to 55%, necessitating novel therapeutic modalities. This study introduces terahertz (THz) photoneuromodulation as an innovative physical intervention for depression, offering several advantages over conventional pharmacological or optogenetic approaches. Mild THz photoneuromodulation circumvents the need for exogenous agents or genetic modifications, mitigating potential risks while precisely modulating neurotransmitter levels and neuronal excitability to alleviate depression-like behaviors. In a chronic restraint stress (CRS) mouse model, THz photostimulation rapidly attenuated hyperactivity and increased serotonin levels by 107.5% ± 45.3% in lateral orbitofrontal cortex glutamatergic neurons (OFC^Glu) compared to those treated with antidepressants. This led to marked improvements in depressive-like behaviors and cognitive function. Furthermore, THz modulation of OFC activity recapitulated the effects of chemogenetic inhibition, underscoring the OFC's pivotal role in regulating depressive states. This research unveils THz photoneuromodulation as a promising, safe, rapid-acting, and durable neurotherapeutic strategy addressing persistent unmet needs in depression treatment.